Submitted by Anonymous (not verified) on 12 May 2026 - 15:08
Human medicines European public assessment report (EPAR): Xbonzy, denosumab, Date of authorisation: 17/11/2025, Revision: 2, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Xbonzy, denosumab, Date of authorisation: 17/11/2025, Revision: 2, Status: Authorised